Navigating The Rise In Chronic Diseases With Ai-Driven Diagnosis: The Driving Engine Behind Artificial Intelligence in Healthcare Diagnosis Market Evolution in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Artificial Intelligence in Healthcare Diagnosis Market Size Growth Forecast: What to Expect by 2025?
The healthcare diagnosis sector of artificial intelligence has seen an impressive growth in its market size recently. The market value is projected to rise from $23.18 billion in 2024 to $33.03 billion in 2025, reflecting a compound annual growth rate (CAGR) of 42.5%. Factors such as advancements in medical imaging, availability and transformation of data in digital form, optimization of clinical workflow, investments in research and development, and dearth of healthcare professionals have contributed to this growth in the historic period.

How Will the Artificial Intelligence in Healthcare Diagnosis Market Size Evolve and Grow by 2029?
In the coming years, the market size for artificial intelligence in healthcare diagnosis is predicted to witness stupendous growth, eventually reaching $153.4 billion in 2029 with a compound annual growth rate (CAGR) of 46.8%. The upswing during this projection period can be linked to the incorporation of AI in precision medicine, seamless integration with electronic health records, expansion in the realm of medical imaging analysis, growth of wearable health technology, as well as regulatory support and set standards. Key trends for this forecast timeframe are the implementation of explainable AI in healthcare, AI-led early disease detection schemes, integration with telehealth, use of AI in pathology and histopathology, and AI-assisted point-of-care diagnostics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report

What Drivers Are Propelling the Growth of Artificial Intelligence in Healthcare Diagnosis Market Forward?
The escalating prevalence of chronic illnesses is predicted to stimulate the expansion of the artificial intelligence in healthcare diagnosis market. These diseases develop slowly over time and often flare up intermittently, making them long-term health concerns. AI in healthcare diagnosis holds the potential to significantly influence the management and diagnosis of such diseases by assisting in cost reduction and optimizing resource utilization. It empowers healthcare providers to make improved decisions, identify high-risk patients, and offer more personalized care. For instance, the World Health Organization, a Switzerland-based agency of the United Nations, reported in September 2022 that there were 41 million fatalities worldwide, 74% of which were due to non-communicable diseases (NCDs) or chronic illnesses. These include 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Accordingly, the increasing prevalence of chronic diseases is fuelling the growth of the artificial intelligence in healthcare diagnosis market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12609&type=smp

Which Emerging Trends Are Transforming the Artificial Intelligence in Healthcare Diagnosis Market in 2025?
The rise of technological development is an emerging trend that is gaining traction in the realm of artificial intelligence in healthcare diagnostics. Major firms in this sector are focusing on the development of cutting-edge technologies to maintain their market standing. For example, Genomic Vision, a biotechnology company based in France, unveiled FiberSmart, an AI-powered software, in March 2023 to automate the detection and quantification of fluorescent signals on combed DNA molecules. FiberSmart provides a straightforward and user-friendly platform, enabling rapid analysis of DNA replication signals to extract pivotal parameters that describe replication kinetics. In comparison with Genomic Vision's existing software applications, this program leverages sophisticated AI methodologies to visualize, detect, and assess DNA replication kinetics with thrice the accuracy and ten times the speed. The easily navigable interface and ergonomic design of FiberSmart facilitate swift analysis of DNA replication signals to ascertain key factors defining the kinetics of replication.

What Are the Key Segments in the Artificial Intelligence in Healthcare Diagnosis Market?
The artificial intelligence in healthcare diagnosismarket covered in this report is segmented -

1) By Component: Software, Services, Hardware
2) By Diagnosis: Cardiology, Oncology, Pathology, Radiology, Chest And Lung, Neurology, Other Diagnoses
3) By Modality: MRI (Magnetic Resonance Imaging), CT (Computed Tomography), X-ray, Ultrasound
4) By Application: In Vivo Diagnostics, In Vitro Diagnostics
5) By End-User: Hospitals, Diagnostics Imaging Centers, Diagnostics Laboratories, Other End-Users

Subsegments:
1) By Software: Diagnostic Software, Imaging Analysis Software, Predictive Analytics Software
2) By Services: Consulting Services, Implementation Services, Maintenance And Support Services
3) By Hardware: Diagnostic Imaging Devices, AI-Powered Medical Devices, Data Storage And Processing Hardware

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12609&type=smp

Who Are the Key Players Shaping the Artificial Intelligence in Healthcare Diagnosis Market's Competitive Landscape?
Major companies operating in the artificial intelligence in healthcare diagnosis market include Johnson and Johnson Private Limited, Intel Corporation, International Business Machines Corporation, Medtronic, Nvidia Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare, Agfa-Gevaert Group, Google Deep Mind, Babylon Health, HeartFlow Inc., Corti HQ, Aidoc, Aidoc Medical Ltd., Imagen Technologies, AliveCor Inc., Digital Diagnostics Inc., Enlitic Inc., NovaSignal Corp., Cleerly Inc., Butterfly Network Inc., IBM Watson Health, Arterys Inc., Zebra Medical Vision Inc., Vuno Inc., Riverain Technologies, CloudMedX Inc., Neural Analytics Inc.

What Geographic Markets Are Powering Growth in the Artificial Intelligence in Healthcare Diagnosis Market?
North America was the largest region in the artificial intelligence in healthcare diagnosis market in 2024. The regions covered in the artificial intelligence in healthcare diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12609

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.